⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
AI-Driven Bispecific Antibody Development Attracts $1+ Billion in Pharma Investments Amid Clinical Risk Mitigation Focus
globenewswire.com
SNY
PFE
AMGN
REGN
Marquis Who's Who Interviews and Honors Guy Plunkett III, PhD, for Excellence in Bacteriology, Genomics and Higher Education
accessnewswire.com
ALGN
CRIS
REGN
GILD
AMGN
BIIB
VRTX
ILMN
NTLA
EDIT
EXAS
PACB
NVDA
AMD
INTC
MU
GOOG
MSFT
IBM
ORCL
CRM
ADBE
CSCO
ACN
BABA
JD
PDD
BIDU
IQ
HTHT
XPEV
NIO
LI
TSLA
RIVN
LCID
F
GM
STLA
VWAGY
TM
HMC
AGNC
PLTR
SNOW
DDOG
SMCI
ASML
KLAC
LRCX
AMAT
ADI
TXN
QCOM
MCHP
NXPI
ON
INFY
WIT
SAP
HPQ
DELL
MSI
AVGO
MRVL
WDC
SE
BILI
EDU
RLX
BEKE
TAL
Trust3 AI Joins NVIDIA Inception Program to Accelerate Adoption of Data and AI
prnewswire.com
NVDA
SNOW
AMGN
AAPL
CMCSA
NTES
INTU
NWL
ADSK
Z
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
prnewswire.com
AMGN
Global Heart Hub finds women delay seeking heart care by continuing to put others first
prnewswire.com
AMGN
NVS
Patient Monitoring Devices Market worth $76.11 billion by 2031 | MarketsandMarkets™
prnewswire.com
MDT
ABT
DXCM
GEHC
BSX
MASI
BIIB
AMGN
GILD
BMY
MRK
PFE
JNJ
BAX
BOSC
Aspen Neuroscience Appoints Jeff Boerneke as General Counsel and Secretary
prnewswire.com
GOSS
AMGN
GlycoNex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar SPD8
prnewswire.com
AMGN
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
globenewswire.com
NVS
TLX
PFE
EXEL
LLY
XNCR
BTE
ORIC
MRK
ABBV
BMY
AZN
AMGN
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX